Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.

NCT04050098 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes

Interventions

DRUG: gemigliptin 50 mg and metformin hydrochloride 1000 mg prolonged release
DRUG: Gemigliptin tartrate sesquihydrate and metformin

Sponsor

LG Chem